Iovance Biotherapeutics Inc. buy BiotechBee
Start price
24.06.23
/
50%
€7.14
Target price
30.11.25
€9.00
Performance (%)
7.45%
End price
14.12.24
€7.67
Summary
This prediction ended on 14.12.24 with a price of €7.67. With a performance of 7.45%, the BUY prediction by BiotechBee for Iovance Biotherapeutics Inc. closed with a slight gain. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Iovance Biotherapeutics Inc. | 13.340% | 13.340% | -66.564% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
According to BiotechBee what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Lion Biotechnologies Inc diskutieren
Buy mit Kursziel 9,0
In the thread Trading Lion Biotechnologies Inc
Buy beendet

